Membrane CD14, but not soluble CD14, is used by exoenzyme S from P. aeruginosa to signal proinflammatory cytokine production

Journal of Leukocyte Biology

Volumn 90, Issue 1, 2011, Pages 189-198

  Berenger, Byron M ^a   Hamill, Jay ^a   Stack, Danuta ^a   Montgomery, Elisha ^a   Huston, Shaunna M ^a   Timm McCann, Martina ^a   Epelman, Slava ^a   Mody, Christopher H ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Lipid binding protein (LBP); Lipopolysaccharide (LPS); Serum; Toll like receptor (TLR)

Indexed keywords

CD14 ANTIGEN; COLECALCIFEROL; EXOENZYME S; LIPOPOLYSACCHARIDE; MEMBRANE CD14 ANTIGEN; SOLUBLE CD14 ANTIGEN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; BLOOD COMPONENT; CELL INTERACTION; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PSEUDOMONAS AERUGINOSA; RAT;

ADP RIBOSE TRANSFERASES; ANTIGENS, CD14; BACTERIAL TOXINS; CELL LINE; CELL MEMBRANE; CYTOKINES; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SIGNAL TRANSDUCTION;

PSEUDOMONAS AERUGINOSA;

EID: 79959835621     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0510265     Document Type: Article

References (76)

1. Moreno, C., Merino, J., Ramirez, N., Echeverria, A., Pastor, F., Sanchez- Ibarrola, A. (2004) Lipopolysaccharide needs soluble CD14 to interact with TLR4 in human monocytes depleted of membrane CD14. Microbes Infect. 6, 990-995.
2. Ohnishi, T., Muroi, M., Tanamoto, K. (2007) The lipopolysacchariderecognition mechanism in cells expressing TLR4 and CD14 but lacking MD-2. FEMS Immunol. Med. Microbiol. 51, 84-91.
3. Akashi, S., Saitoh, S., Wakabayashi, Y., Kikuchi, T., Takamura, N., Nagai, Y., Kusumoto, Y., Fukase, K., Kusumoto, S., Adachi, Y., Kosugi, A., Miyake, K. (2003) Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14. J. Exp. Med. 198, 1035-1042.
4. Vesy, C. J., Kitchens, R. L., Wolfbauer, G., Albers, J. J., Munford, R. S. (2000) Lipopolysaccharide-binding protein and phospholipid transfer protein release lipopolysaccharides from gram-negative bacterial membranes. Infect. Immun. 68, 2410-2417.
5. Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., Mathison, J. C. (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249, 1431-1433.
6. Hailman, E., Vasselon, T., Kelley, M., Busse, L. A., Hu, M. C., Lichenstein, H. S., Detmers, P. A., Wright, S. D. (1996) Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14. J. Immunol. 156, 4384-4390.
7. Schröder, N. W., Heine, H., Alexander, C., Manukyan, M., Eckert, J., Hamann, L., Gobel, U. B., Schumann, R. R. (2004) Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses. J. Immunol. 173, 2683-2691.
8. Schröder, N. W., Morath, S., Alexander, C., Hamann, L., Hartung, T., Zahringer, U., Gobel, U. B., Weber, J. R., Schumann, R. R. (2003) Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharidebinding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J. Biol. Chem. 278, 15587-15594.
9. Nakata, T., Yasuda, M., Fujita, M., Kataoka, H., Kiura, K., Sano, H., Shibata, K. (2006) CD14 directly binds to triacylated lipopeptides and facilitates recognition of the lipopeptides by the receptor complex of Toll-like receptors 2 and 1 without binding to the complex. Cell. Microbiol. 8, 1899-1909.
10. Albright, S., Chen, B., Holbrook, K., Jain, N. U. (2008) Solution NMR studies provide structural basis for endotoxin pattern recognition by the innate immune receptor CD14. Biochem. Biophys. Res. Commun. 368, 231- 237.
11. Wurfel, M. M., Hailman, E., Wright, S. D. (1995) Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein. J. Exp. Med. 181, 1743-1754.
12. Kitchens, R. L., Thompson, P. A., O'Keefe, G. E., Munford, R. S. (2000) Plasma constituents regulate LPS binding to, and release from, the monocyte cell surface. J. Endotoxin Res. 6, 477-482.
13. Thompson, P. A., Tobias, P. S., Viriyakosol, S., Kirkland, T. N., Kitchens, R. L. (2003) Lipopolysaccharide (LPS)-binding protein inhibits responses to cell-bound LPS. J. Biol. Chem. 278, 28367-28371.
14. Dziarski, R., Viriyakosol, S., Kirkland, T. N., Gupta, D. (2000) Soluble CD14 enhances membrane CD14-mediated responses to peptidoglycan: structural requirements differ from those for responses to lipopolysaccharide. Infect. Immun. 68, 5254-5260.
15. Gangloff, S. C., Zahringer, U., Blondin, C., Guenounou, M., Silver, J., Goyert, S. M. (2005) Influence of CD14 on ligand interactions between lipopolysaccharide and its receptor complex. J. Immunol. 175, 3940-3945.
16. Jiang, Z., Georgel, P., Du, X., Shamel, L., Sovath, S., Mudd, S., Huber, M., Kalis, C., Keck, S., Galanos, C., Freudenberg, M., Beutler, B. (2005) CD14 is required for MyD88-independent LPS signaling. Nat. Immunol. 6, 565-570.
17. Janot, L., Sirard, J-C., Secher, T., Noulin, N., Fick, L., Akira, S., Uematsu, S., Didierlaurent, A., Hussell, T., Ryffel, B., Erard, F. (2009) Radioresistant cells expressing TLR5 control the respiratory epithelium's innate immune responses to flagellin. Eur. J. Immunol. 39, 1587-1596.
18. Dolganiuc, A., Oak, S., Kodys, K., Golenbock, D. T., Finberg, R. W., Kurt- Jones, E., Szabo, G. (2004) Hepatitis C core and nonstructural 3 proteins trigger Toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 127, 1513-1524.
19. Mossman, K. L., Mian, M. F., Lauzon, N. M., Gyles, C. L., Lichty, B., Mackenzie, R., Gill, N., Ashkar, A. A. (2008) Cutting edge: FimH adhesion of type 1 fimbriae is a novel TLR4 ligand. J. Immunol. 181, 6702-6706.
20. Ashkar, A. A., Mossman, K. L., Coombes, B. K., Gyles, C. L., Mackenzie, R. (2008) FimH adhesin of type 1 fimbriae is a potent inducer of innate antimicrobial responses which requires TLR4 and type 1 interferon signaling. PLoS Pathog. 4, e1000233.
21. van de Beek, D., de Gans, J., McIntyre, P., Prasad, K. (2004) Steroids in adults with acute bacterial meningitis: a systematic review. Lancet Infect. Dis. 4, 139-143.
22. Prasad, K., Singh, M. B. (2008) Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst. Rev. CD002244.
23. Prasad K. Singh M.B. (1990) Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome. N. Engl. J. Med. 323, 1500-1504.
24. Schimke, J., Mathison, J., Morgiewicz, J., Ulevitch, R. J. (1998) Anti-CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin. Proc. Natl. Acad. Sci. USA 95, 13875-13880.
25. Tasaka, S., Ishizaka, A., Yamada, W., Shimizu, M., Koh, H., Hasegawa, N., Adachi, Y., Yamaguchi, K. (2003) Effect of CD14 blockade on endotoxininduced acute lung injury in mice. Am. J. Respir. Cell Mol. Biol. 29, 252-258.
26. Frevert, C. W., Matute-Bello, G., Skerrett, S. J., Goodman, R. B., Kajikawa, O., Sittipunt, C., Martin, T. R. (2000) Effect of CD14 blockade in rabbits with Escherichia coli pneumonia and sepsis. J. Immunol. 164, 5439-5445.
27. Elson, G., Dunn-Siegrist, I., Daubeuf, B., Pugin, J. (2007) Contribution of Toll-like receptors to the innate immune response to gram-negative and gram-positive bacteria. Blood 109, 1574-1583.
28. Opal, S. M., Palardy, J. E., Parejo, N., Jasman, R. L. (2003) Effect of anti- CD14 monoclonal antibody on clearance of Escherichia coli bacteremia and endotoxemia. Crit. Care Med. 31, 929-932.
29. Burns, J. L., Gibson, R. L., McNamara, S., Yim, D., Emerson, J., Rosenfeld, M., Hiatt, P., McCoy, K., Castile, R., Smith, A. L., Ramsey, B. W. (2001) Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J. Infect. Dis. 183, 444-452.
30. Lyczak, J. B., Cannon, C. L., Pier, G. B. (2000) Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect. 2, 1051-1060.
31. Feltman, H., Schulert, G., Khan, S., Jain, M., Peterson, L., Hauser, A. R. (2001) Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. Microbiology 147, 2659-2669.
32. Lanotte, P., Watt, S., Mereghetti, L., Dartiguelongue, N., Rastegar-Lari, A., Goudeau, A., Quentin, R. (2004) Genetic features of Pseudomonas aeruginosa isolates from cystic fibrosis patients compared with those of isolates from other origins. J. Med. Microbiol. 53, 73-81.
33. Grimwood, K., Semple, R. A., Rabin, H. R., Sokol, P. A., Woods, D. E. (1993) Elevated exoenzyme expression by Pseudomonas aeruginosa is correlated with exacerbations of lung disease in cystic fibrosis. Pediatr. Pulmonol. 15, 135-139.
34. Rumbaugh, K. P., Griswold, J. A., Hamood, A. N. (1999) Pseudomonas aeruginosa strains obtained from patients with tracheal, urinary tract and wound infection: variations in virulence factors and virulence genes. J. Hosp. Infect. 43, 211-218.
35. Shaver, C. M., Hauser, A. R. (2004) Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung. Infect. Immun. 72, 6969-6977.
36. Nicas, T. I., Bradley, J., Lochner, J. E., Iglewski, B. H. (1985) The role of exoenzyme S in infections with Pseudomonas aeruginosa. J. Infect. Dis. 152, 716-721.
37. Nicas, T. I., Iglewski, B. H. (1985) The contribution of exoproducts to virulence of Pseudomonas aeruginosa. Can. J. Microbiol. 31, 387-392.
38. Epelman, S., Bruno, T. F., Neely, G. G., Woods, D. E., Mody, C. H. (2000) Pseudomonas aeruginosa exoenzyme S induces transcriptional expression of proinflammatory cytokines and chemokines. Infect. Immun. 68, 4811-4814.
39. Epelman, S., Stack, D., Bell, C., Wong, E., Neely, G. G., Krutzik, S., Miyake, K., Kubes, P., Zbytnuik, L. D., Ma, L. L., Xie, X., Woods, D. E., Mody, C. H. (2004) Different domains of Pseudomonas aeruginosa exoenzyme S activate distinct TLRs. J. Immunol. 173, 2031-2040.
40. Kulich, S. M., Frank, D. W., Barbieri, J. T. (1993) Purification and characterization of exoenzyme S from Pseudomonas aeruginosa 388. Infect. Immun. 61, 307-313.
41. Epelman, S., Neely, G. G., Ma, L. L., Gjomarkaj, M., Pace, E., Melis, M., Woods, D. E., Mody, C. H. (2002) Distinct fates of monocytes and T cells directly activated by Pseudomonas aeruginosa exoenzyme S. J. Leukoc. Biol. 71, 458-468.
42. Flo, T. H., Halaas, O., Torp, S., Ryan, L., Lien, E., Dybdahl, B., Sundan, A., Espevik, T. (2001) Differential expression of Toll-like receptor 2 in human cells. J. Leukoc. Biol. 69, 474-481.
43. Hirschfeld, M., Kirschning, C. J., Schwandner, R., Wesche, H., Weis, J. H., Wooten, R. M., Weis, J. J. (1999) Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by Toll-like receptor 2. J. Immunol. 163, 2382-2386.
44. Mody, C. H., Buser, D. E., Syme, R. M., Woods, D. E. (1995) Pseudomonas aeruginosa exoenzyme S induces proliferation of human T lymphocytes. Infect. Immun. 63, 1800-1805.
45. Takahashi, T., Nakamura, K., Iho, S. (1997) Differentiation of myeloid cells and 1,25-dihydroxyvitamin D3. Leuk. Lymphoma 27, 25-33.
46. Schwende, H., Fitzke, E., Ambs, P., Dieter, P. (1996) Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25- dihydroxyvitamin D3. J. Leukoc. Biol. 59, 555-561.
47. Finberg, R. W., Re, F., Popova, L., Golenbock, D. T., Kurt-Jones, E. A. (2004) Cell activation by Toll-like receptors: role of LBP and CD14. J. Endotoxin Res. 10, 413-418.
48. Knight, D. A., Finck-Barbancon, V., Kulich, S. M., Barbieri, J. T. (1995) Functional domains of Pseudomonas aeruginosa exoenzyme S. Infect. Immun. 63, 3182-3186.
49. Finberg, R. W., Kurt-Jones, E. A. (2006) CD14: chaperone or matchmaker? Immunity 24, 127-129.
50. Yu, B., Hailman, E., Wright, S. D. (1997) Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids. J. Clin. Invest. 99, 315-324.
51. Bsibsi, M., Bajramovic, J. J., Van Duijvenvoorden, E., Persoon, C., Ravid, R., Van Noort, J. M., Vogt, M. H. (2007) Identification of soluble CD14 as an endogenous agonist for Toll-like receptor 2 on human astrocytes by genome-scale functional screening of glial cell derived proteins. Glia 55, 473-482.
52. Kaczorowski, D. J., Nakao, A., Vallabhaneni, R., Mollen, K. P., Sugimoto, R., Kohmoto, J., Zuckerbraun, B. S., McCurry, K. R., Billiar, T. R. (2009) Mechanisms of Toll-like receptor 4 (TLR4)-mediated inflammation after cold ischemia/reperfusion in the heart. Transplantation 87, 1455-1463.
53. Filipp, D., Alizadeh-Khiavi, K., Richardson, C., Palma, A., Paredes, N., Takeuchi, O., Akira, S., Julius, M. (2001) Soluble CD14 enriched in colostrums and milk induces B cell growth and differentiation. Proc. Natl. Acad. Sci. USA 98, 603-608.
54. Kitchens, R. L., Thompson, P. A., Viriyakosol, S., O'Keefe, G. E., Munford, R. S. (2001) Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins. J. Clin. Invest. 108, 485-493.
55. Erridge, C., Kennedy, S., Spickett, C. M., Webb, D. J. (2008) Oxidized phospholipid inhibition of Toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4. J. Biol. Chem. 283, 24748-24759.
56. Von Schlieffen, E., Oskolkova, O. V., Schabbauer, G., Gruber, F., Bluml, S., Genest, M., Kadl, A., Marsik, C., Knapp, S., Chow, J., Leitinger, N., Binder, B. R., Bochkov, V. N. (2009) Multi-hit inhibition of circulating and cell-associated components of the Toll-like receptor 4 pathway by oxidized phospholipids. Arterioscler. Thromb. Vasc. Biol. 29, 356-362.
57. Lee, C., An, H. J., Kim, J. L., Lee, H., Paik, S. G. (2009) Inhibitory effect of a phosphatidyl ethanolamine derivative on LPS-induced sepsis. Mol. Cells 27, 251-255.
58. Miyake, K. (2006) Roles for accessory molecules in microbial recognition by Toll-like receptors. J. Endotoxin Res. 12, 195-204.
59. Triantafilou, M., Miyake, K., Golenbock, D. T., Triantafilou, K. (2002) Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J. Cell Sci. 115, 2603-2611.
60. Pfeiffer, A., Bottcher, A., Orso, E., Kapinsky, M., Nagy, P., Bodnar, A., Spreitzer, I., Liebisch, G., Drobnik, W., Gempel, K., Horn, M., Holmer, S., Hartung, T., Multhoff, G., Schutz, G., Schindler, H., Ulmer, A. J., Heine, H., Stelter, F., Schutt, C., Rothe, G., Szollosi, J., Damjanovich, S., Schmitz, G. (2001) Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts. Eur. J. Immunol. 31, 3153-3164.
61. Latz, E., Visintin, A., Lien, E., Fitzgerald, K. A., Monks, B. G., Kurt-Jones, E. A., Golenbock, D. T., Espevik, T. (2002) Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the Toll-like receptor 4-MD- 2-CD14 complex in a process that is distinct from the initiation of signal transduction. J. Biol. Chem. 277, 47834-47843.
62. Epelman, S., Berenger, B., Stack, D., Neely, G. G., Ma, L. L., Mody, C. H. (2008) Microbial products activate monocytic cells through detergent resistant membrane microdomains. Am. J. Respir. Cell Mol. Biol. 39, 657- 665.
63. Wang, P. Y., Kitchens, R. L., Munford, R. S. (1995-1996) Bacterial ipopolysaccharide binds to CD14 in low-density domains of the monocytemacrophage plasma membrane. J. Inflamm. 47, 126-137.
64. Stefanová, I., Corcoran, M. L., Horak, E. M., Wahl, L. M., Bolen, J. B., Horak, I. D. (1993) Lipopolysaccharide induces activation of CD14-associated protein tyrosine kinase p53/56lyn. J. Biol. Chem. 268, 20725-20728.
65. Solomon, K. R., Kurt-Jones, E. A., Saladino, R. A., Stack, A. M., Dunn, I. F., Ferretti, M., Golenbock, D., Fleisher, G. R., Finberg, R. W. (1998) Heterotrimeric G proteins physically associated with the lipopolysaccharide receptor CD14 modulate both in vivo and in vitro responses to lipopolysaccharide. J. Clin. Invest. 102, 2019-2027.
66. Georgel, P., Jiang, Z., Kunz, S., Janssen, E., Mols, J., Hoebe, K., Bahram, S., Oldstone, M. B., Beutler, B. (2007) Vesicular stomatitis virus glycoprotein G activates a specific antiviral Toll-like receptor 4-dependent pathway. Virology 362, 304-313.
67. Doyle, S., Vaidya, S. A., O'Connell, R., Dadgostar, H., Dempsey, P. W., Wu, T-T., Rao, G., Sun, R., Haberland, M. E., Modlin, R. L., Cheng, G. (2002) IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 17, 251-263.
68. Frey, E. A., Miller, D. S., Jahr, T. G., Sundan, A., Bazil, V., Espevik, T., Finlay, B. B., Wright, S. D. (1992) Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med. 176, 1665-1671.
69. Gioannini, T. L., Teghanemt, A., Zhang, D., Coussens, N. P., Dockstader, W., Ramaswamy, S., Weiss, J. P. (2004) Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations. Proc. Natl. Acad. Sci. USA 101, 4186-4191.
70. Perera, P-Y., Mayadas, T. N., Takeuchi, O., Akira, S., Zaks-Zilberman, M., Goyert, S. M., Vogel, S. N. (2001) CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression. J. Immunol. 166, 574-581.
71. Lee, H. K., Dunzendorfer, S., Soldau, K., Tobias, P. S. (2006) Doublestranded RNA-mediated TLR3 activation is enhanced by CD14. Immunity 24, 153-163.
72. Haziot, A., Rong, G. W., Lin, X. Y., Silver, J., Goyert, S. M. (1995) Recombinant soluble CD14 prevents mortality in mice treated with endotoxin (lipopolysaccharide). J. Immunol. 154, 6529-6532.
73. Stelter, F., Witt, S., Furll, B., Jack, R. S., Hartung, T., Schutt, C. (1998) Different efficacy of soluble CD14 treatment in high- and low-dose LPS models. Eur. J. Clin. Invest. 28, 205-213.
74. Lamping, N., Dettmer, R., Schroder, N. W., Pfeil, D., Hallatschek, W., Burger, R., Schumann, R. R. (1998) LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria. J. Clin. Invest. 101, 2065-2071.
75. Akashi-Takamura, S., Miyake, K. (2008) TLR accessory molecules. Curr. Opin. Immunol. 20, 420-425.
76. Orr, S. L., Tobias, P. (2000) LPS and LAM activation of the U373 astrocytoma cell line: differential requirement for CD14. J. Endotoxin Res. 6, 215-222.